Cardoso Rhanderson, Shaw Leslee J, Blumenthal Roger S, Nasir Khurram, Ferraro Richard, Maron David J, Blaha Michael J, Gulati Martha, Bhatt Deepak L, Blankstein Ron
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.
Icahn School of Medicine, Mount Sinai, New York, New York, United States.
Am J Prev Cardiol. 2022 Jun 30;11:100365. doi: 10.1016/j.ajpc.2022.100365. eCollection 2022 Sep.
A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.
2021年美国心脏协会/美国心脏病学会/美国超声心动图学会/美国胸科医师学会/美国急诊医师学会/心血管造影和介入学会/心血管磁共振学会胸痛指南的一项核心原则是，预防性治疗对于非阻塞性或阻塞性冠状动脉疾病（CAD）患者至关重要。因此，这篇社论提供了独特的见解，强调了预防心脏病学在整个新指南中的作用。CAD首次被定义为也包括非阻塞性斑块。这一定义基于这样一个事实，即与没有非阻塞性斑块的个体相比，有非阻塞性斑块的个体发生动脉粥样硬化事件的风险更高。在此，我们重点介绍与非阻塞性CAD诊断和管理相关的指南建议。我们还重点介绍强调预防性治疗重要性的建议。采用这些建议有可能加强预防性治疗并改善患者预后。
